These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The evidence for low-dose CT screening of lung cancer. Ruchalski K, Gutierrez A, Genshaft S, Abtin F, Suh R. Clin Imaging; 2016 Apr; 40(2):288-95. PubMed ID: 26362352 [Abstract] [Full Text] [Related]
46. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
47. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial. Gierada DS, Pinsky PF. Chest; 2021 Feb 01; 159(2):862-869. PubMed ID: 32822676 [Abstract] [Full Text] [Related]
52. [The role of low-dose computed tomography in lung cancer screening]. Ágh T, Szilberhorn L, Csanádi M, Széles G, Vokó Z, Ádám G, Kallai Á. Orv Hetil; 2022 Sep 11; 163(37):1464-1471. PubMed ID: 36088623 [Abstract] [Full Text] [Related]
53. Low-dose computed tomography screening in Japan. Nawa T, Nakagawa T, Mizoue T, Endo K. J Thorac Imaging; 2015 Mar 11; 30(2):108-14. PubMed ID: 25658475 [Abstract] [Full Text] [Related]
54. A population-based cohort study to evaluate the effectiveness of lung cancer screening using low-dose CT in Hitachi city, Japan. Nawa T, Fukui K, Nakayama T, Sagawa M, Nakagawa T, Ichimura H, Mizoue T. Jpn J Clin Oncol; 2019 Feb 01; 49(2):130-136. PubMed ID: 30541133 [Abstract] [Full Text] [Related]
55. Low-dose computed tomographic screening for lung cancer. Christensen JD, Chiles C. Clin Chest Med; 2015 Jun 01; 36(2):147-60, vii. PubMed ID: 26024597 [Abstract] [Full Text] [Related]
56. Queensland Lung Cancer Screening Study: rationale, design and methods. Marshall HM, Bowman RV, Crossin J, Lau MA, Slaughter RE, Passmore LH, McCaul EM, Courtney DA, Windsor MN, Yang IA, Smith IR, Keir BJ, Hayes TJ, Redmond SJ, Zimmerman PV, Fong KM. Intern Med J; 2013 Feb 01; 43(2):174-82. PubMed ID: 22471951 [Abstract] [Full Text] [Related]
57. Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China. Zhao Z, Wang Y, Wu W, Yang Y, Du L, Dong H. JAMA Netw Open; 2022 May 02; 5(5):e2213634. PubMed ID: 35608858 [Abstract] [Full Text] [Related]
58. Screening high-risk populations for lung cancer: guideline recommendations. Roberts H, Walker-Dilks C, Sivjee K, Ung Y, Yasufuku K, Hey A, Lewis N, Lung Cancer Screening Guideline Development Group. J Thorac Oncol; 2013 Oct 02; 8(10):1232-7. PubMed ID: 24457233 [Abstract] [Full Text] [Related]
60. [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version)]. Zhou Q, Fan Y, Wang Y, Qiao Y, Wang G, Huang Y, Wang X, Wu N, Zhang G, Zheng X, Bu H, Li Y, Wei S, Chen L, Hu C, Shi Y, Sun Y. Zhongguo Fei Ai Za Zhi; 2018 Feb 20; 21(2):67-75. PubMed ID: 29526173 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]